Papers
8
Total Citations
138
H-Index
4
About
Dr. Linda Dey is a leading urologic surgeon whose research focuses on advancing robot-assisted radical cystectomy (RARC) for bladder cancer, with a particular emphasis on optimizing surgical techniques and patient recovery. Her most impactful work, cited 61 times, demonstrated the successful integration of enhanced recovery programmes (ERP) into an established totally intracorporeal RARC service, significantly improving perioperative outcomes. Dr. Dey has made seminal contributions to pelvic organ-preserving (POP) RARC in female patients, showing that this approach can preserve sexual and urinary function without compromising oncological safety—a finding with 33 citations that has reshaped surgical practice. Her 28-cited study on ureteric stricture rates provided crucial evidence from a high-volume center, establishing benchmarks for complication management. More recently, her long-term multicentre analysis (2025) evaluated 12-year survival outcomes for non-muscle-invasive bladder cancer patients undergoing RARC, offering vital prognostic data. Dr. Dey’s work has consistently pushed the boundaries of minimally invasive urologic oncology, blending technical innovation with rigorous outcomes research to improve quality of life for bladder cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7Robot Assisted Intracorporeal Urinary Diversion: Orthotopic Neobladder2 citations · 2024
- 8